The Cardiovascular Surgical Devices Market is estimated to be valued at USD 57.9 billion in 2025 and is projected to reach USD 122.7 billion by 2035, registering a compound annual growth rate (CAGR) of 7.8% over the forecast period.
| Metric | Value |
|---|---|
| Cardiovascular Surgical Devices Market Estimated Value in (2025 E) | USD 57.9 billion |
| Cardiovascular Surgical Devices Market Forecast Value in (2035 F) | USD 122.7 billion |
| Forecast CAGR (2025 to 2035) | 7.8% |
The Cardiovascular Surgical Devices market is experiencing robust growth, driven by the increasing prevalence of cardiovascular diseases, rising geriatric population, and advancements in surgical technologies. The market is being supported by the growing need for early diagnosis, minimally invasive procedures, and efficient post-operative care. Innovations in device design, materials, and integration with digital monitoring systems are enhancing procedural safety and patient outcomes.
Hospitals and specialized cardiac centers are investing heavily in modern surgical equipment to meet the increasing demand for cardiovascular interventions. Regulatory emphasis on quality standards, safety compliance, and reimbursement policies further reinforce adoption. Increasing awareness about preventive care and timely intervention is driving patient demand for diagnostic and surgical solutions.
The combination of technological innovation, expanding healthcare infrastructure, and government initiatives for cardiovascular health is creating a favorable environment for market expansion As surgical procedures become more precise and outcome-focused, the market is expected to sustain growth, with emerging economies providing significant opportunities for deployment of advanced cardiovascular surgical devices.
The cardiovascular surgical devices market is segmented by device type, application, end-user, and geographic regions. By device type, cardiovascular surgical devices market is divided into Electrocardiogram (ECG), Remote Cardiac Monitoring, Other Diagnostic And Monitoring Devices, Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheters, Grafts, Heart Valves, Stents, and Other Therapeutic And Surgical Devices. In terms of application, cardiovascular surgical devices market is classified into Coronary Artery Disease, Arrhythmia, Heart Failure, Structural Heart Disease, Hypertension, and Others. Based on end-user, cardiovascular surgical devices market is segmented into Hospitals & Cardiac Centers, Ambulatory Surgical Centers, Home-Care Settings, and Specialty Clinics. Regionally, the cardiovascular surgical devices industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The electrocardiogram (ECG) segment is projected to hold 32.2% of the market revenue in 2025, establishing it as the leading device type. Growth in this segment is being driven by the widespread use of ECG devices for real-time cardiac monitoring, early diagnosis of arrhythmias, and perioperative assessment during cardiovascular surgeries. ECG devices provide non-invasive, accurate, and continuous monitoring capabilities, which are critical for both diagnostic and surgical applications.
Integration with digital health platforms, wireless monitoring, and AI-based analytics has further enhanced clinical utility and adoption in hospitals and cardiac centers. The scalability of ECG devices across outpatient, inpatient, and remote monitoring settings supports their widespread application.
Increasing prevalence of coronary artery disease and rising demand for preventive cardiac care reinforce the leadership of this segment As technological improvements continue to enhance precision, reliability, and connectivity, ECG devices are expected to maintain their dominant position in the cardiovascular surgical device market, providing critical support for patient management and clinical decision-making.
The coronary artery disease application segment is expected to account for 35.6% of the market revenue in 2025, making it the largest application area. Its growth is being driven by the rising prevalence of coronary artery disease globally and the increasing need for timely interventions to prevent severe complications such as heart attacks and chronic heart failure. Cardiovascular surgical devices play a critical role in diagnosis, intraoperative guidance, and post-surgical monitoring for these patients.
Adoption is further reinforced by hospitals and cardiac centers implementing advanced diagnostic and therapeutic workflows to improve patient outcomes. Integration of real-time monitoring, imaging, and AI-enabled decision support systems enhances procedural efficiency and safety.
Patient awareness campaigns and preventive health programs have also contributed to higher detection and treatment rates, boosting device utilization As demand for effective management of coronary artery disease continues to grow, this application segment is expected to remain a key driver of market expansion, supporting both clinical outcomes and healthcare infrastructure development.
The hospitals and cardiac centers end-user segment is projected to hold 41.2% of the market revenue in 2025, establishing it as the leading end-user category. Growth in this segment is being driven by the increasing number of cardiovascular surgeries and procedures performed in specialized healthcare facilities. Hospitals and cardiac centers are investing in advanced surgical devices, including ECG monitors, imaging systems, and minimally invasive tools, to improve diagnostic accuracy, patient safety, and procedural outcomes.
The integration of cardiovascular devices with hospital information systems and electronic medical records supports efficient patient management and compliance with regulatory requirements. High patient inflow, especially in urban centers, and the need for continuous monitoring of high-risk patients further drive adoption.
Government and private sector initiatives to strengthen cardiac care infrastructure are also supporting growth As hospitals and cardiac centers continue to expand services, implement state-of-the-art equipment, and focus on improving patient outcomes, this end-user segment is expected to maintain its leadership, driving sustained revenue growth for cardiovascular surgical devices.
A World Health Organization factsheet states that 17.5 million people the world over die every year because of cardiovascular diseases. This amounts to nearly 31% of the total yearly deaths. A large number of these deaths occur in low or middle-income countries and are primarily caused by strokes or a heart attack.
Such ominous statistics are the primary reason driving the growth of the global cardiovascular surgical devices market. Cardiovascular surgery is performed to cure heart tissue defects by replacing heart valves if they are blocked, or grafting or replacing the heart tissue in case of damage.
The two main types of heart surgeries are open heart surgery and closed heart surgery.
The global cardiovascular surgical devices market comprises beating heart surgery systems, cardiac aberration devices, cardiopulmonary bypass equipment, and perfusion disposables. The device to be used depends upon the type and the purpose of the surgery.
Going forward, the cardiovascular surgical devices market is expected to play an important role in improving the quality of life of the aged population, along with those individuals who may suffer from some kind of heart disease.
| Country | CAGR |
|---|---|
| China | 10.5% |
| India | 9.8% |
| Germany | 9.0% |
| France | 8.2% |
| UK | 7.4% |
| USA | 6.6% |
| Brazil | 5.9% |
The Cardiovascular Surgical Devices Market is expected to register a CAGR of 7.8% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 10.5%, followed by India at 9.8%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 5.9%, yet still underscores a broadly positive trajectory for the global Cardiovascular Surgical Devices Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 9.0%. The USA Cardiovascular Surgical Devices Market is estimated to be valued at USD 21.3 billion in 2025 and is anticipated to reach a valuation of USD 40.5 billion by 2035. Sales are projected to rise at a CAGR of 6.6% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 2.8 billion and USD 1.8 billion respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 57.9 Billion |
| Device Type | Electrocardiogram (ECG), Remote Cardiac Monitoring, Other Diagnostic And Monitoring Devices, Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheters, Grafts, Heart Valves, Stents, and Other Therapeutic And Surgical Devices |
| Application | Coronary Artery Disease, Arrhythmia, Heart Failure, Structural Heart Disease, Hypertension, and Others |
| End-User | Hospitals & Cardiac Centers, Ambulatory Surgical Centers, Home-Care Settings, and Specialty Clinics |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Abbott, GE HealthCare, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., Siemens Healthcare GmbH, BIOTRONIK SE & Co. KG, Canon Medical Systems Asia Pte. Ltd., B. Braun SE, LivaNova PLC, Cardinal Health, Medtronic, and Boston Scientific Corporation |
The global cardiovascular surgical devices market is estimated to be valued at USD 57.9 billion in 2025.
The market size for the cardiovascular surgical devices market is projected to reach USD 122.7 billion by 2035.
The cardiovascular surgical devices market is expected to grow at a 7.8% CAGR between 2025 and 2035.
The key product types in cardiovascular surgical devices market are electrocardiogram (ecg), remote cardiac monitoring, other diagnostic and monitoring devices, cardiac assist devices, cardiac rhythm management devices, catheters, grafts, heart valves, stents and other therapeutic and surgical devices.
In terms of application, coronary artery disease segment to command 35.6% share in the cardiovascular surgical devices market in 2025.
Explore Similar Insights
Cardiovascular Surgical Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
